Search results
Pages
-
- Prognostic significance of PD-1/PD-L1 expression in uveal melanoma: correlation with tumor-infiltrating lymphocytes and clinicopathological parameters
-
- Remote control: the cancer cell-intrinsic mechanisms that dictate systemic inflammation and anti-tumor immunity
-
- Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response
-
- Efficacy of nivolumab and ipilimumab in patients with malignant pleural mesothelioma is related to a subtype of effector memory cytotoxic T cells
-
- Exploring and modulating the tumor immune microenvironment: Towards improving patient outcomes of immunotherapy in lung cancer
-
- Vaccination and targeted therapy using liposomes : opportunities for treatment of atherosclerosis and cancer
-
- A brief report on combination chemotherapy and anti-programmed death (ligand) 1 treatment in small-cell lung cancer
-
- Survival outcomes of patients with advanced mucosal melanoma diagnosed from 2013 to 2017 in the Netherlands
-
- Renal toxicity from pemetrexed and pembrolizumab in the era of combination therapy in patients with metastatic nonsquamous cell NSCLC
-
- Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients
-
- Photodynamic cancer therapy enhances accumulation of nanoparticles in tumor-associated myeloid cells
-
- Synergizing systemic responses by combining immunotherapy with radiotherapy in metastatic non-small cell lung cancer: The potential of the abscopal effect
-
- Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry